BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong ME, Jaworowski A, Hearps AC. The HIV Reservoir in Monocytes and Macrophages. Front Immunol 2019;10:1435. [PMID: 31297114 DOI: 10.3389/fimmu.2019.01435] [Cited by in Crossref: 102] [Cited by in F6Publishing: 111] [Article Influence: 25.5] [Reference Citation Analysis]
Number Citing Articles
1 Adhikari R, Witwer KW, Wiberg KJ, Chen YC. The interplay among HIV, monocytes/macrophages, and extracellular vesicles: a systematic review. J Leukoc Biol 2023;113:255-87. [PMID: 36802000 DOI: 10.1093/jleuko/qiac021] [Reference Citation Analysis]
2 Czuba-Wojnilowicz E, Klemm V, Cortez-Jugo C, Turville S, Aggarwal A, Caruso F, Kelleher AD, Ahlenstiel CL. Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types. Mol Pharm 2023. [PMID: 36848493 DOI: 10.1021/acs.molpharmaceut.2c01030] [Reference Citation Analysis]
3 Marini S, Huber A, Cash MN, Salemi M, Cook RL, Borsa P, Mavian C. Oral CBD treatment is associated to an anti-inflammatory gene expression signature in myeloid cells of people living with HIV.. [DOI: 10.1101/2023.02.24.23285761] [Reference Citation Analysis]
4 Kodidela S, Sinha N, Kumar A, Zhou L, Godse S, Kumar S. Extracellular vesicles released from macrophages modulates interleukin-1β in astrocytic and neuronal cells. Sci Rep 2023;13:3005. [PMID: 36810605 DOI: 10.1038/s41598-023-29746-y] [Reference Citation Analysis]
5 de Gea-Grela A, Moreno S. Controversies in the Design of Strategies for the Cure of HIV Infection. Pathogens 2023;12. [PMID: 36839593 DOI: 10.3390/pathogens12020322] [Reference Citation Analysis]
6 Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, Gaskill PJ. Dopamine, Immunity, and Disease. Pharmacol Rev 2023;75:62-158. [PMID: 36757901 DOI: 10.1124/pharmrev.122.000618] [Reference Citation Analysis]
7 Zerbato JM, Avihingsanon A, Singh KP, Zhao W, Deleage C, Rosen E, Cottrell ML, Rhodes A, Dantanarayana A, Tumpach C, Tennakoon S, Crane M, Price DJ, Braat S, Mason H, Roche M, Kashuba ADM, Revill PA, Audsley J, Lewin SR. HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy. EBioMedicine 2023;87:104391. [PMID: 36502576 DOI: 10.1016/j.ebiom.2022.104391] [Reference Citation Analysis]
8 Ezeonwumelu IJ, Garcia-Vidal E, Riveira-Muñoz E, Felip E, Gutiérrez-Chamorro L, Calba I, Massanella M, Sirera G, Clotet B, Ballana E, Badia R. Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection. Int J Mol Sci 2022;23. [PMID: 36499329 DOI: 10.3390/ijms232315000] [Reference Citation Analysis]
9 Anthony-Gonda K, Ray A, Su H, Wang Y, Xiong Y, Lee D, Block A, Chilunda V, Weiselberg J, Zemelko L, Wang YY, Kleinsorge-Block S, Reese JS, de Lima M, Ochsenbauer C, Kappes JC, Dimitrov DS, Orentas R, Deeks SG, Rutishauser RL, Berman JW, Goldstein H, Dropulić B. In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells. JCI Insight 2022;7. [PMID: 36345941 DOI: 10.1172/jci.insight.161698] [Reference Citation Analysis]
10 Chen M, Li M, Budai MM, Rice AP, Kimata JT, Mohan M, Wang J. Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies. J Leukoc Biol 2022;112:1245-59. [PMID: 35362118 DOI: 10.1002/JLB.4MR0222-606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Mcallister JJ, Dahiya S, Berman R, Collins M, Nonnemacher MR, Burdo TH, Wigdahl B. Altered recruitment of Sp isoforms to HIV-1 long terminal repeat between differentiated monoblastic cell lines and primary monocyte-derived macrophages. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.971293] [Reference Citation Analysis]
12 Dickey LL, Martins LJ, Planelles V, Hanley TM. HIV-1-induced type I IFNs promote viral latency in macrophages. J Leukoc Biol 2022;112:1343-56. [PMID: 35588262 DOI: 10.1002/JLB.4MA0422-616R] [Reference Citation Analysis]
13 Joseph J, Daley W, Lawrence D, Lorenzo E, Perrin P, Rao VR, Tsai SY, Varthakavi V. Role of macrophages in HIV pathogenesis and cure: NIH perspectives. J Leukoc Biol 2022;112:1233-43. [PMID: 36073341 DOI: 10.1002/JLB.4MR0722-619R] [Reference Citation Analysis]
14 Waight E, Zhang C, Mathews S, Kevadiya BD, Lloyd KCK, Gendelman HE, Gorantla S, Poluektova LY, Dash PK. Animal models for studies of HIV-1 brain reservoirs. J Leukoc Biol 2022;112:1285-95. [PMID: 36044375 DOI: 10.1002/JLB.5VMR0322-161R] [Reference Citation Analysis]
15 Rose R, Gonzalez-Perez MP, Nolan D, Ganta KK, LaFleur T, Cross S, Brody R, Lamers SL, Luzuriaga K. Distinct HIV-1 Population Structure across Meningeal and Peripheral T Cells and Macrophage Lineage Cells. Microbiol Spectr 2022;10:e0250822. [PMID: 36173332 DOI: 10.1128/spectrum.02508-22] [Reference Citation Analysis]
16 Real F, Zhu A, Huang B, Belmellat A, Sennepin A, Vogl T, Ransy C, Revol M, Arrigucci R, Lombès A, Roth J, Gennaro ML, Bouillaud F, Cristofari S, Bomsel M. S100A8-mediated metabolic adaptation controls HIV-1 persistence in macrophages in vivo. Nat Commun 2022;13:5956. [PMID: 36220814 DOI: 10.1038/s41467-022-33401-x] [Reference Citation Analysis]
17 Wang Q, Shan L. Inflammasomes in Human Immunodeficiency Virus Type 1 Infection. Infect Dis Immun 2022;2:248-52. [PMID: 36798147 DOI: 10.1097/ID9.0000000000000070] [Reference Citation Analysis]
18 Ode H, Saito A, Washizaki A, Seki Y, Yoshida T, Harada S, Ishii H, Shioda T, Yasutomi Y, Matano T, Miura T, Akari H, Iwatani Y. Development of a novel Macaque-Tropic HIV-1 adapted to cynomolgus macaques. J Gen Virol 2022;103. [PMID: 36205476 DOI: 10.1099/jgv.0.001790] [Reference Citation Analysis]
19 Cui J, Meshesha M, Churgulia N, Merlo C, Fuchs E, Breakey J, Jones J, Stivers JT. Replication-competent HIV-1 in human alveolar macrophages and monocytes despite nucleotide pools with elevated dUTP. Retrovirology 2022;19:21. [PMID: 36114511 DOI: 10.1186/s12977-022-00607-2] [Reference Citation Analysis]
20 Ho N, Agarwal S, Milani M, Cantore A, Buchholz CJ, Thalheimer FB. In vivo generation of CAR T cells in the presence of human myeloid cells. Mol Ther Methods Clin Dev 2022;26:144-56. [PMID: 35795778 DOI: 10.1016/j.omtm.2022.06.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Khan MA, Singh SK. Atom-based 3D-QSAR and DFT analysis of 5-substituted 2-acylaminothiazole derivatives as HIV-1 latency-reversing agents. J Biomol Struct Dyn 2022;:1-16. [PMID: 35971967 DOI: 10.1080/07391102.2022.2112078] [Reference Citation Analysis]
22 Lê-bury G, Chen Y, Rhen JM, Grenier JK, Singhal A, Russell DG, Boliar S. HIV-1 latent infection triggers broader epigenomic and transcriptional changes in protein-coding and long non-coding RNAs than active infection of SupT1 cells.. [DOI: 10.1101/2022.08.10.503487] [Reference Citation Analysis]
23 Bowen NE, Oo A, Kim B. Mechanistic Interplay between HIV-1 Reverse Transcriptase Enzyme Kinetics and Host SAMHD1 Protein: Viral Myeloid-Cell Tropism and Genomic Mutagenesis. Viruses 2022;14:1622. [PMID: 35893688 DOI: 10.3390/v14081622] [Reference Citation Analysis]
24 Sukegawa S, Takeuchi H. Toward the unveiling of HIV-1 dynamics: Involvement of monocytes/macrophages in HIV-1 infection. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.934892] [Reference Citation Analysis]
25 Mensching L, Hoelzemer A. NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses. Front Immunol 2022;13:883728. [PMID: 35711433 DOI: 10.3389/fimmu.2022.883728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Martínez-Román P, Crespo-Bermejo C, Valle-Millares D, Lara-Aguilar V, Arca-Lafuente S, Martín-Carbonero L, Ryan P, de Los Santos I, López-Huertas MR, Palladino C, Muñoz-Muñoz M, Fernández-Rodríguez A, Coiras M, Briz V, On Behalf Of The Covihep Network. Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance. J Clin Med 2022;11. [PMID: 35806864 DOI: 10.3390/jcm11133579] [Reference Citation Analysis]
27 Moran JA, Turner SR, Marsden MD. Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches. Front Immunol 2022;13:905773. [PMID: 35693831 DOI: 10.3389/fimmu.2022.905773] [Reference Citation Analysis]
28 Goh D, Lee JN, Tien T, Lim JCT, Lim S, Tan AS, Liu J, Tan B, Yeong J. Comparison between non-pulmonary and pulmonary immune responses in a HIV decedent who succumbed to COVID-19. Gut 2022;71:1231-4. [PMID: 34376518 DOI: 10.1136/gutjnl-2021-324754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Johnson TP, Nath A. Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis. Curr Opin Infect Dis 2022;35:223-30. [PMID: 35665716 DOI: 10.1097/QCO.0000000000000825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kreider EF, Bar KJ. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies. Curr HIV/AIDS Rep 2022;19:194-206. [PMID: 35404007 DOI: 10.1007/s11904-022-00604-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Kim JG, Shan L. Beyond Inhibition: A Novel Strategy of Targeting HIV-1 Protease to Eliminate Viral Reservoirs. Viruses 2022;14:1179. [PMID: 35746649 DOI: 10.3390/v14061179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
32 Han M, Cantaloube-ferrieu V, Xie M, Armani-tourret M, Woottum M, Pagès J, Colin P, Lagane B, Benichou S. HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages. PLoS Pathog 2022;18:e1010335. [DOI: 10.1371/journal.ppat.1010335] [Reference Citation Analysis]
33 Chitrakar A, Sanz M, Maggirwar SB, Soriano-sarabia N. HIV Latency in Myeloid Cells: Challenges for a Cure. Pathogens 2022;11:611. [DOI: 10.3390/pathogens11060611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Cui J, Meshesha M, Churgulia N, Merlo C, Fuchs E, Breakey J, Jones J, Stivers JT. Replication-competent HIV-1 in human alveolar macrophages and monocytes despite nucleotide pools with elevated dUTP.. [DOI: 10.1101/2022.05.03.490432] [Reference Citation Analysis]
35 Ta TM, Malik S, Anderson EM, Jones AD, Perchik J, Freylikh M, Sardo L, Klase ZA, Izumi T. Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies. Front Microbiol 2022;13:862270. [PMID: 35572626 DOI: 10.3389/fmicb.2022.862270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
36 Sánchez-Díaz L, Espinosa-Sánchez A, Blanco JR, Carnero A. Senotherapeutics in Cancer and HIV. Cells 2022;11:1222. [PMID: 35406785 DOI: 10.3390/cells11071222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Chand S, Demarino C, Gowen A, Cowen M, Al-sharif S, Kashanchi F, Yelamanchili SV. Methamphetamine Induces the Release of Proadhesive Extracellular Vesicles and Promotes Syncytia Formation: A Potential Role in HIV-1 Neuropathogenesis. Viruses 2022;14:550. [DOI: 10.3390/v14030550] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Sergio Monteiro de Almeida M, Tang B, Vaida F, Letendre S, Ellis RJ. Soluble CD14 is subtype-dependent in serum but not in cerebrospinal fluid in people with HIV. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577845] [Reference Citation Analysis]
39 Basova LV, Lukkes SE, Milner R, Ellis RJ, Cherner M, Iudicello J, Marcondes MCG. Polygenic networks in peripheral leukocytes indicate patterns associated with HIV infection and context-dependent effects of cannabis use. Brain Behav Immun Health 2022;20:100414. [PMID: 35128491 DOI: 10.1016/j.bbih.2022.100414] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Han M, Cantaloube-ferrieu V, Xie M, Armani-tourret M, Woottum M, Pagès J, Colin P, Lagane B, Benichou S. HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages.. [DOI: 10.1101/2022.02.07.479340] [Reference Citation Analysis]
41 MacDonald DM, Collins G, Wendt CH, Wolfson J, Tracy RP, Rhame F, Deeks S, Rizza SA, Temesgen Z, Morse C, Liappis AP, Sereti I, Baker JV, Kunisaki KM. Short Communication: A Pilot Study of the Effects of Losartan Versus Placebo on Pneumoproteins in HIV: A Secondary Analysis of a Randomized Double Blind Study. AIDS Res Hum Retroviruses 2022;38:127-30. [PMID: 33749317 DOI: 10.1089/AID.2020.0285] [Reference Citation Analysis]
42 Lee MJ, Fidler S, Frater J. Immunotherapeutic approaches to HIV cure and remission. Curr Opin Infect Dis 2022;35:31-41. [PMID: 34873077 DOI: 10.1097/QCO.0000000000000803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Kleinman AJ, Pandrea I, Apetrei C. So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research. Viruses 2022;14:135. [PMID: 35062339 DOI: 10.3390/v14010135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Xu H, Blair RV, Veazey RS, Wang X. Immunopathogenesis in HIV-associated pediatric tuberculosis. Pediatr Res 2022;91:21-6. [PMID: 33731810 DOI: 10.1038/s41390-021-01393-x] [Reference Citation Analysis]
45 J N, T H, J S. IPSC-derived models in Africa: An HIV perspective. Biochimie 2022. [DOI: 10.1016/j.biochi.2022.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Zlotnikov ID, Kudryashova EV. Computer simulation of the Receptor-Ligand Interactions of Mannose Receptor CD206 in Comparison with the Lectin Concanavalin A Model. Biochemistry (Mosc) 2022;87:54-69. [PMID: 35491020 DOI: 10.1134/S0006297922010059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Alteri C, Piermatteo L, Silberstein FC, Svicher V, Perno CF. Human Monocyte-Derived Macrophages (MDM): Model 1 (GM-CSF). Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-1871-4_8] [Reference Citation Analysis]
48 Злотников И, Кудряшова Е. Компьютерное моделирование лиганд-рецепторных взаимодействий маннозного рецептора CD206 в сравнении с модельным лектином конканавалином А. БМ 2022;87:68-85. [DOI: 10.31857/s0320972522010055] [Reference Citation Analysis]
49 Röling M, Mollapour Sisakht M, Ne E, Moulos P, Crespo R, Stoszko M, De Crignis E, Bodmer H, Kan TW, Akbarzadeh M, Harokopos V, Hatzis P, Palstra RJ, Mahmoudi T. A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency. mBio 2021;12:e0298021. [PMID: 34872356 DOI: 10.1128/mBio.02980-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Reece MD, Taylor RR, Song C, Gavegnano C. Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators. Front Immunol 2021;12:768695. [PMID: 34790202 DOI: 10.3389/fimmu.2021.768695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Segura J, He B, Ireland J, Zou Z, Shen T, Roth G, Sun PD. The Role of L-Selectin in HIV Infection. Front Microbiol 2021;12:725741. [PMID: 34659153 DOI: 10.3389/fmicb.2021.725741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Niu F, Liao K, Hu G, Moidunny S, Roy S, Buch S. HIV Tat-Mediated Induction of Monocyte Transmigration Across the Blood-Brain Barrier: Role of Chemokine Receptor CXCR3. Front Cell Dev Biol 2021;9:724970. [PMID: 34527676 DOI: 10.3389/fcell.2021.724970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Nguyen H, Wilson H, Jayakumar S, Kulkarni V, Kulkarni S. Efficient Inhibition of HIV Using CRISPR/Cas13d Nuclease System. Viruses 2021;13:1850. [PMID: 34578431 DOI: 10.3390/v13091850] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
54 Harwood O, O'Connor S. Therapeutic Potential of IL-15 and N-803 in HIV/SIV Infection. Viruses 2021;13:1750. [PMID: 34578331 DOI: 10.3390/v13091750] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
55 Rohde D, Nahrendorf M. Bad company: monocytes in HIV and atherosclerosis. Cardiovasc Res 2021;117:993-4. [PMID: 33693568 DOI: 10.1093/cvr/cvab058] [Reference Citation Analysis]
56 Duan S, Xu X, Wang J, Huang L, Peng J, Yu T, Zhou Y, Cheng K, Liu S. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4+ T Cells. J Virol 2021;95:e0081621. [PMID: 34133900 DOI: 10.1128/JVI.00816-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Alfageme-Abello O, Porret R, Perreau M, Perez L, Muller YD. Chimeric antigen receptor T-cell therapy for HIV cure. Curr Opin HIV AIDS 2021;16:88-97. [PMID: 33560017 DOI: 10.1097/COH.0000000000000665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Relaño-Rodríguez I, Espinar-Buitrago MS, Martín-Cañadilla V, Gómez-Ramírez R, Muñoz-Fernández MÁ. G2-S16 Polyanionic Carbosilane Dendrimer Can Reduce HIV-1 Reservoir Formation by Inhibiting Macrophage Cell to Cell Transmission. Int J Mol Sci 2021;22:8366. [PMID: 34445073 DOI: 10.3390/ijms22168366] [Reference Citation Analysis]
59 Borrajo López A, Penedo MA, Rivera-Baltanas T, Pérez-Rodríguez D, Alonso-Crespo D, Fernández-Pereira C, Olivares JM, Agís-Balboa RC. Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders? Biomedicines 2021;9:925. [PMID: 34440127 DOI: 10.3390/biomedicines9080925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Nguyen H, Wilson H, Jayakumar S, Kulkarni V, Kulkarni S. Efficient inhibition of HIV using CRISPR/Cas13d nuclease system.. [DOI: 10.1101/2021.07.21.453273] [Reference Citation Analysis]
61 Meng FZ, Liu JB, Wang X, Wang P, Hu WH, Hou W, Ho WZ. TLR7 Activation of Macrophages by Imiquimod Inhibits HIV Infection through Modulation of Viral Entry Cellular Factors. Biology (Basel) 2021;10:661. [PMID: 34356516 DOI: 10.3390/biology10070661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
62 Szaniawski MA, Spivak AM. Senotherapeutics for HIV and aging. Curr Opin HIV AIDS 2020;15:83-93. [PMID: 31833962 DOI: 10.1097/COH.0000000000000609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
63 Gautam N, McMillan JM, Kumar D, Bade AN, Pan Q, Kulkarni TA, Li W, Sillman B, Smith NA, Shetty BLD, Szlachetka A, Edagwa BJ, Gendelman HE, Alnouti Y. Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir. Nat Commun 2021;12:3453. [PMID: 34103484 DOI: 10.1038/s41467-021-23668-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
64 Blanco A, Mahajan T, Coronado RA, Ma K, Demma DR, Dar RD. Synergistic Chromatin-Modifying Treatments Reactivate Latent HIV and Decrease Migration of Multiple Host-Cell Types. Viruses 2021;13:1097. [PMID: 34201394 DOI: 10.3390/v13061097] [Reference Citation Analysis]
65 Dash PK, Gorantla S, Poluektova L, Hasan M, Waight E, Zhang C, Markovic M, Edagwa B, Machhi J, Olson KE, Wang X, Mosley RL, Kevadiya B, Gendelman HE. Humanized Mice for Infectious and Neurodegenerative disorders. Retrovirology 2021;18:13. [PMID: 34090462 DOI: 10.1186/s12977-021-00557-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Assis MA, Carranza PG, Ambrosio E. A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV. Viruses 2021;13:722. [PMID: 33919273 DOI: 10.3390/v13050722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Triantafilou K, Ward CJK, Czubala M, Ferris RG, Koppe E, Haffner C, Piguet V, Patel VK, Amrine-Madsen H, Modis LK, Masters SL, Triantafilou M. Differential recognition of HIV-stimulated IL-1β and IL-18 secretion through NLR and NAIP signalling in monocyte-derived macrophages. PLoS Pathog 2021;17:e1009417. [PMID: 33861800 DOI: 10.1371/journal.ppat.1009417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
68 Ziani W, Bauer A, Lu H, Wang X, Wu X, Bar KJ, Li H, Liu D, Shaw GM, Veazey RS, Xu H. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques. J Virol 2021;95:e02198-20. [PMID: 33568508 DOI: 10.1128/JVI.02198-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Sarca AD, Sardo L, Fukuda H, Matsui H, Shirakawa K, Horikawa K, Takaori-Kondo A, Izumi T. FRET-Based Detection and Quantification of HIV-1 Virion Maturation. Front Microbiol 2021;12:647452. [PMID: 33767685 DOI: 10.3389/fmicb.2021.647452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Janssens J, Bruggemans A, Christ F, Debyser Z. Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus. Front Microbiol 2021;12:636642. [PMID: 33868195 DOI: 10.3389/fmicb.2021.636642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
71 Viglianti GA, Planelles V, Hanley TM. Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR. J Virol 2021;95:JVI. [PMID: 33472928 DOI: 10.1128/JVI.02141-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
72 Dillon SM, Wilson CC. Gut Innate Immunity and HIV Pathogenesis. Curr HIV/AIDS Rep 2021;18:128-38. [PMID: 33687703 DOI: 10.1007/s11904-021-00544-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Veenhuis RT, Abreu CM, Shirk EN, Gama L, Clements JE. HIV replication and latency in monocytes and macrophages. Semin Immunol 2021;:101472. [PMID: 33648815 DOI: 10.1016/j.smim.2021.101472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
74 Ziani W, Shao J, Wang X, Russell-Lodrigue K, Liu YZ, Montaner LJ, Veazey RS, Xu H. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption. J Virol 2021;95:e02064-20. [PMID: 33408173 DOI: 10.1128/JVI.02064-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
75 Wang X, Xu H. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption. Viruses 2021;13:335. [PMID: 33670027 DOI: 10.3390/v13020335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
76 Wolf G, Singh NJ. Modular Approaches to Understand the Immunobiology of Human Immunodeficiency Virus Latency. Viral Immunol 2021;34:365-75. [PMID: 33600238 DOI: 10.1089/vim.2020.0171] [Reference Citation Analysis]
77 Boliar S, Russell DG. Lnc(ing)RNAs to the "shock and kill" strategy for HIV-1 cure. Mol Ther Nucleic Acids 2021;23:1272-80. [PMID: 33717648 DOI: 10.1016/j.omtn.2021.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
78 Dufour C, Gantner P, Fromentin R, Chomont N. The multifaceted nature of HIV latency. J Clin Invest 2020;130:3381-90. [PMID: 32609095 DOI: 10.1172/JCI136227] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
79 Pham V, Marsden MD. Can macrophages form a latent reservoir of HIV? Future Virology 2021;16:75-77. [DOI: 10.2217/fvl-2020-0381] [Reference Citation Analysis]
80 Lopes JR, Chiba DE, Dos Santos JL. HIV latency reversal agents: A potential path for functional cure? Eur J Med Chem 2021;213:113213. [PMID: 33540228 DOI: 10.1016/j.ejmech.2021.113213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Gautam N, Mcmillan JM, Kumar D, Bade AN, Pan Q, Kulkarni TA, Li W, Smith NA, Dyavar Shetty BL, Sillman B, Szlachetka A, Edagwa BJ, Gendelman HE, Alnouti Y. Lipophilic Nanocrystal Prodrug-Release Defines the Extended Pharmacokinetic Profiles of a Year-Long Cabotegravir.. [DOI: 10.1101/2021.01.18.427147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Teer E, Joseph DE, Glashoff RH, Faadiel Essop M. Monocyte/Macrophage-Mediated Innate Immunity in HIV-1 Infection: From Early Response to Late Dysregulation and Links to Cardiovascular Diseases Onset. Virol Sin 2021;36:565-76. [PMID: 33400091 DOI: 10.1007/s12250-020-00332-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
83 Bailon L, Mothe B, Berman L, Brander C. Novel Approaches Towards a Functional Cure of HIV/AIDS. Drugs 2020;80:859-68. [PMID: 32436069 DOI: 10.1007/s40265-020-01322-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
84 Pagano N, Laurent-rolle M, Hsu JC, Vogels CB, Grubaugh ND, Manuelidis L, the Yale IMPACT Research Team. Long SARS-CoV-2 nucleocapsid sequences in blood monocytes collected soon after hospital admission.. [DOI: 10.1101/2020.12.16.423113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Byanova K, Kunisaki KM, Vasquez J, Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev Respir Med 2021;15:71-87. [PMID: 33167728 DOI: 10.1080/17476348.2021.1848556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Shelton EM, Reeves DB, Bender Ignacio RA. Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions. AIDS Rev 2020;23:28-39. [PMID: 33105471 DOI: 10.24875/AIDSRev.20000001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Denaro F, Benedetti F, Worthington MD, Scapagnini G, Krauss CC, Williams S, Bryant J, Davis H, Latinovic OS, Zella D. The HIV-1 Transgenic Rat: Relevance for HIV Noninfectious Comorbidity Research. Microorganisms 2020;8:E1643. [PMID: 33114165 DOI: 10.3390/microorganisms8111643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
88 Szaniawski MA, Spivak AM. Senotherapeutics and HIV-1 Persistence. Curr HIV/AIDS Rep 2020;17:219-25. [PMID: 32356089 DOI: 10.1007/s11904-020-00496-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
89 Schynkel T, Szaniawski MA, Spivak AM, Bosque A, Planelles V, Vandekerckhove L, Trypsteen W. Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIV. Int J Mol Sci 2020;21:E7741. [PMID: 33086748 DOI: 10.3390/ijms21207741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
90 Kannambath S, Jarvis JN, Wake RM, Longley N, Loyse A, Matzaraki V, Aguirre-Gamboa R, Wijmenga C, Doyle R, Paximadis M, Tiemessen CT, Kumar V, Pittman A, Meintjes G, Harrison TS, Netea MG, Bicanic T. Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans. Open Forum Infect Dis 2020;7:ofaa489. [PMID: 33269293 DOI: 10.1093/ofid/ofaa489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
91 Priyanka, Wadhwa R, Chaudhuri R, Nag TC, Seth P. Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis. J Neuroinflammation 2020;17:276. [PMID: 32951595 DOI: 10.1186/s12974-020-01912-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
92 Covino DA, Kaczor-Urbanowicz KE, Lu J, Chiantore MV, Fiorucci G, Vescio MF, Catapano L, Purificato C, Galluzzo CM, Amici R, Andreotti M, Gauzzi MC, Pellegrini M, Fantuzzi L. Transcriptome Profiling of Human Monocyte-Derived Macrophages Upon CCL2 Neutralization Reveals an Association Between Activation of Innate Immune Pathways and Restriction of HIV-1 Gene Expression. Front Immunol 2020;11:2129. [PMID: 33072075 DOI: 10.3389/fimmu.2020.02129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
93 Cernasev A, Veve MP, Cory TJ, Summers NA, Miller M, Kodidela S, Kumar S. Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders. Pharmacy (Basel) 2020;8:E168. [PMID: 32932786 DOI: 10.3390/pharmacy8030168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
94 Stevens DM, Adiseshaiah P, Dasa SSK, Potter TM, Skoczen SL, Snapp KS, Cedrone E, Patel N, Busman-Sahay K, Rosen EP, Sykes C, Cottrell M, Dobrovolskaia MA, Estes JD, Kashuba ADM, Stern ST. Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV. Mol Pharm 2020;17:3794-812. [PMID: 32841040 DOI: 10.1021/acs.molpharmaceut.0c00562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ferreira IATM, Porterfield JZ, Gupta RK, Mlcochova P. Cell Cycle Regulation in Macrophages and Susceptibility to HIV-1. Viruses 2020;12:E839. [PMID: 32751972 DOI: 10.3390/v12080839] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
96 Ditiatkovski M, Mukhamedova N, Dragoljevic D, Hoang A, Low H, Pushkarsky T, Fu Y, Carmichael I, Hill AF, Murphy AJ, Bukrinsky M, Sviridov D. Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction. J Biol Chem 2020;295:13377-92. [PMID: 32732283 DOI: 10.1074/jbc.RA120.014642] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
97 León-Rivera R, Morsey B, Niu M, Fox HS, Berman JW. Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities. mBio 2020;11. [PMID: 32723919 DOI: 10.1128/mBio.01037-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
98 Ehinger E, Ghosheh Y, Pramod AB, Lin J, Hanna DB, Mueller K, Durant CP, Baas L, Qi Q, Wang T, Buscher K, Anastos K, Lazar JM, Mack WJ, Tien PC, Cohen MH, Ofotokun I, Gange S, Heath SL, Hodis HN, Tracy RP, Landay AL, Kaplan RC, Ley K. Classical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV. Cardiovasc Res 2021;117:1166-77. [PMID: 32658258 DOI: 10.1093/cvr/cvaa188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
99 Akiyama H, Gummuluru S. HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages. Viruses 2020;12:E711. [PMID: 32630058 DOI: 10.3390/v12070711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
100 Viglianti GA, Planelles V, Hanley TM. Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR.. [DOI: 10.1101/2020.05.18.103333] [Reference Citation Analysis]
101 Holder KA, Grant MD. TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir. Front Cell Infect Microbiol 2020;10:175. [PMID: 32432050 DOI: 10.3389/fcimb.2020.00175] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
102 Giese S, Lawrence SP, Mazzon M, Nijmeijer BM, Marsh M. The Nef Protein of the Macrophage Tropic HIV-1 Strain AD8 Counteracts Human BST-2/Tetherin. Viruses 2020;12:E459. [PMID: 32325729 DOI: 10.3390/v12040459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
103 Gornalusse GG, Valdez R, Fenkart G, Vojtech L, Fleming LM, Pandey U, Hughes SM, Levy CN, Dela Cruz EJ, Calienes FL, Kirby AC, Fialkow MF, Lentz GM, Wagoner J, Jing L, Koelle DM, Polyak SJ, Fredricks DN, McElrath MJ, Wald A, Hladik F. Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells. J Virol 2020;94:e01904-19. [PMID: 32051273 DOI: 10.1128/JVI.01904-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
104 Torrentes-Carvalho A, Sánchez-Arcila JC, Azamor T, Barbosa LS, Hottz ED, Gandini M, Bozza FA, da Cunha RV, de Oliveira Pinto LM, Damasco PV, de Azeredo EL. Apoptosis characterization in mononuclear blood leukocytes of HIV patients during dengue acute disease. Sci Rep 2020;10:6351. [PMID: 32286360 DOI: 10.1038/s41598-020-62776-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
105 Agarwal Y, Beatty C, Biradar S, Castronova I, Ho S, Melody K, Bility MT. Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies. Retrovirology 2020;17:8. [PMID: 32276640 DOI: 10.1186/s12977-020-00515-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
106 Thomas J, Ruggiero A, Paxton WA, Pollakis G. Measuring the Success of HIV-1 Cure Strategies. Front Cell Infect Microbiol 2020;10:134. [PMID: 32318356 DOI: 10.3389/fcimb.2020.00134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
107 Tanaka M, Toldi J, Vécsei L. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines. Int J Mol Sci 2020;21:E2431. [PMID: 32244523 DOI: 10.3390/ijms21072431] [Cited by in Crossref: 93] [Cited by in F6Publishing: 99] [Article Influence: 31.0] [Reference Citation Analysis]
108 Dash PK, Kevadiya BD, Su H, Banoub MG, Gendelman HE. Pathways towards human immunodeficiency virus elimination. EBioMedicine 2020;53:102667. [PMID: 32114397 DOI: 10.1016/j.ebiom.2020.102667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
109 Giese S, Lawrence SP, Mazzon M, Nijmeijer BM, Marsh M. The Nef protein of the macrophage tropic HIV-1 strain AD8 counteracts human Bst-2/tetherin.. [DOI: 10.1101/2020.02.07.938464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Sinha A, Feinstein M. Epidemiology, pathophysiology, and prevention of heart failure in people with HIV. Prog Cardiovasc Dis 2020;63:134-41. [PMID: 31987806 DOI: 10.1016/j.pcad.2020.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
111 Lu T, Wang K. The effect of opioid abuse on HIV infected nervous system. Ibrain 2020;6:34-40. [DOI: 10.1002/j.2769-2795.2020.tb00051.x] [Reference Citation Analysis]
112 Falcinelli SD, Ceriani C, Margolis DM, Archin NM. New Frontiers in Measuring and Characterizing the HIV Reservoir. Front Microbiol 2019;10:2878. [PMID: 31921056 DOI: 10.3389/fmicb.2019.02878] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
113 Prabhu VM, Singh AK, Padwal V, Nagar V, Patil P, Patel V. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors. Front Immunol 2019;10:2849. [PMID: 31867010 DOI: 10.3389/fimmu.2019.02849] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
114 Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, Mallon PWG, Marcello A, Van Lint C, Rohr O, Schwartz C. Microglial Cells: The Main HIV-1 Reservoir in the Brain. Front Cell Infect Microbiol 2019;9:362. [PMID: 31709195 DOI: 10.3389/fcimb.2019.00362] [Cited by in Crossref: 137] [Cited by in F6Publishing: 140] [Article Influence: 34.3] [Reference Citation Analysis]
115 Hashemi P, Sadowski I. Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens. Med Res Rev 2020;40:881-908. [PMID: 31608481 DOI: 10.1002/med.21638] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
116 Darcis G, Berkhout B, Pasternak AO. The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like. Front Immunol 2019;10:2251. [PMID: 31616425 DOI: 10.3389/fimmu.2019.02251] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]